These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20189212)

  • 1. Low- and high-risk human papillomavirus E7 proteins regulate p130 differently.
    Barrow-Laing L; Chen W; Roman A
    Virology; 2010 May; 400(2):233-9. PubMed ID: 20189212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteasomal degradation of p130 facilitate cell cycle deregulation and impairment of cellular differentiation in high-risk Human Papillomavirus 16 and 18 E7 transfected cells.
    Gandhi S; Nor Rashid N; Mohamad Razif MF; Othman S
    Mol Biol Rep; 2021 Jun; 48(6):5121-5133. PubMed ID: 34169395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonconserved lysine residues attenuate the biological function of the low-risk human papillomavirus E7 protein.
    Genovese NJ; Broker TR; Chow LT
    J Virol; 2011 Jun; 85(11):5546-54. PubMed ID: 21411531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of repressive p130-DREAM complexes by human papillomavirus 16 E6/E7 oncoproteins is required for cell-cycle progression in cervical cancer cells.
    Nor Rashid N; Yusof R; Watson RJ
    J Gen Virol; 2011 Nov; 92(Pt 11):2620-2627. PubMed ID: 21813705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation.
    Zhang B; Chen W; Roman A
    Proc Natl Acad Sci U S A; 2006 Jan; 103(2):437-42. PubMed ID: 16381817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Casein kinase II motif-dependent phosphorylation of human papillomavirus E7 protein promotes p130 degradation and S-phase induction in differentiated human keratinocytes.
    Genovese NJ; Banerjee NS; Broker TR; Chow LT
    J Virol; 2008 May; 82(10):4862-73. PubMed ID: 18321970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human papillomavirus type 58 E7 oncoprotein modulates cell cycle regulatory proteins and abrogates cell cycle checkpoints.
    Zhang W; Li J; Kanginakudru S; Zhao W; Yu X; Chen JJ
    Virology; 2010 Feb; 397(1):139-44. PubMed ID: 19945133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A postulated role of p130 in telomere maintenance by human papillomavirus oncoprotein E7.
    Zhang W; Tian Y; Chen JJ; Zhao W; Yu X
    Med Hypotheses; 2012 Aug; 79(2):178-80. PubMed ID: 22595804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of microRNA-mRNA Target Pairs by Human Papillomavirus 16 Oncoproteins.
    Harden ME; Prasad N; Griffiths A; Munger K
    mBio; 2017 Jan; 8(1):. PubMed ID: 28049151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pocket proteins suppress head and neck cancer.
    Shin MK; Pitot HC; Lambert PF
    Cancer Res; 2012 Mar; 72(5):1280-9. PubMed ID: 22237625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of pocket protein dream complexes by E7 proteins of different types of human papillomaviruses.
    Nor Rashid N; Yusof R; Watson RJ
    Acta Virol; 2013; 57(4):447-51. PubMed ID: 24294959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent.
    Armstrong DJ; Roman A
    Virology; 1997 Dec; 239(1):238-46. PubMed ID: 9426463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Conserved Amino Acid in the C Terminus of Human Papillomavirus E7 Mediates Binding to PTPN14 and Repression of Epithelial Differentiation.
    Hatterschide J; Brantly AC; Grace M; Munger K; White EA
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
    Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
    Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditionally activated E7 proteins of high-risk and low-risk human papillomaviruses induce S phase in postmitotic, differentiated human keratinocytes.
    Banerjee NS; Genovese NJ; Noya F; Chien WM; Broker TR; Chow LT
    J Virol; 2006 Jul; 80(13):6517-24. PubMed ID: 16775338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV 16E7 and 48E7 proteins use different mechanisms to target p130 to overcome cell cycle block.
    Nor Rashid N; Yong ZL; Yusof R; Watson RJ
    Virol J; 2016 Jan; 13():2. PubMed ID: 26728921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vivo analysis of hpv e7 protein association with prb, p107 and p130.
    Hu T; Ferril S; Snider A; Barbosa M
    Int J Oncol; 1995 Jan; 6(1):167-74. PubMed ID: 21556519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of WDHD1 in Human Papillomavirus-Mediated Oncogenesis Identified by Transcriptional Profiling of E7-Expressing Cells.
    Zhou Y; Zhang Q; Gao G; Zhang X; Liu Y; Yuan S; Wang X; Chen JJ
    J Virol; 2016 Jul; 90(13):6071-6084. PubMed ID: 27099318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTPN14 degradation by high-risk human papillomavirus E7 limits keratinocyte differentiation and contributes to HPV-mediated oncogenesis.
    Hatterschide J; Bohidar AE; Grace M; Nulton TJ; Kim HW; Windle B; Morgan IM; Munger K; White EA
    Proc Natl Acad Sci U S A; 2019 Apr; 116(14):7033-7042. PubMed ID: 30894485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV-16 E7 expression up-regulates phospholipase D activity and promotes rapamycin resistance in a pRB-dependent manner.
    Rabachini T; Boccardo E; Andrade R; Perez KR; Nonogaki S; Cuccovia IM; Villa LL
    BMC Cancer; 2018 Apr; 18(1):485. PubMed ID: 29703186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.